-
Signature
-
/s/ Christie Cho as attorney-in-fact
-
Stock symbol
-
RELY
-
Transactions as of
-
Nov 25, 2024
-
Transactions value $
-
-$760,783
-
Form type
-
4
-
Date filed
-
11/27/2024, 04:15 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
RELY |
Common Stock |
Options Exercise |
|
+8.98K |
+0.23% |
|
3.88M |
Nov 25, 2024 |
Direct |
F1, F2 |
transaction |
RELY |
Common Stock |
Tax liability |
-$74.3K |
-3.53K |
-0.09% |
$21.04 |
3.88M |
Nov 25, 2024 |
Direct |
|
transaction |
RELY |
Common Stock |
Options Exercise |
|
+27.6K |
+0.71% |
|
3.91M |
Nov 25, 2024 |
Direct |
F1, F2 |
transaction |
RELY |
Common Stock |
Tax liability |
-$229K |
-10.9K |
-0.28% |
$21.04 |
3.9M |
Nov 25, 2024 |
Direct |
|
transaction |
RELY |
Common Stock |
Sale |
-$458K |
-22.2K |
-0.57% |
$20.62 |
3.87M |
Nov 26, 2024 |
Direct |
F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
RELY |
Restricted Stock Units (RSUs) |
Options Exercise |
$0 |
-8.98K |
-50% |
$0.00 |
8.98K |
Nov 25, 2024 |
Common Stock |
8.98K |
|
Direct |
F2, F5 |
transaction |
RELY |
Restricted Stock Units (RSUs) |
Options Exercise |
$0 |
-27.6K |
-50% |
$0.00 |
27.6K |
Nov 25, 2024 |
Common Stock |
27.6K |
|
Direct |
F2, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: